Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir

被引：0
|
作者：
I. V. Polyakov
B. L. Grigorenko
A. V. Nemukhin
机构：
[1] Emanuel Institute of Biochemical Physics,
[2] Russian Academy of Sciences,undefined
[3] Moscow State University,undefined
来源：
Russian Journal of Physical Chemistry B | 2021年 / 15卷
关键词：
molecular dynamics; coronavirus; RNA polymerase; reaction mechanism; inhibition; favipiravir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 107
页数：4
相关论文
共 50 条
  • [1] Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
    Polyakov, I. V.
    Grigorenko, B. L.
    Nemukhin, A. V.
    RUSSIAN JOURNAL OF PHYSICAL CHEMISTRY B, 2021, 15 (01) : 103 - 107
  • [2] Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
    Peng, Qi
    Peng, Ruchao
    Yuan, Bin
    Wang, Min
    Zhao, Jingru
    Fu, Lifeng
    Qi, Jianxun
    Shi, Yi
    INNOVATION, 2021, 2 (01):
  • [3] In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
    Celik, Ismail
    Erol, Meryem
    Duzgun, Zekeriya
    MOLECULAR DIVERSITY, 2022, 26 (01) : 279 - 292
  • [4] Favipiravir in SARS-CoV-2 Infection: Is it Worth it?
    Batiha, Gaber El-Saber
    Moubarak, Mohamed
    Shaheen, Hazem M.
    Zakariya, Ali M.
    Usman, Ibe M.
    Rauf, Abdur
    Adhikari, Achyut
    Dey, Abhijit
    Alexiou, Athanasios
    Hetta, Helal F.
    Al-Gareeb, Ali I.
    Al-kuraishy, Hayder M.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (14) : 2413 - 2428
  • [5] Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
    Driouich, Jean-Selim
    Cochin, Maxime
    Lingas, Guillaume
    Moureau, Gregory
    Touret, Franck
    Petit, Paul-Remi
    Piorkowski, Geraldine
    Barthelemy, Karine
    Laprie, Caroline
    Coutard, Bruno
    Guedj, Jeremie
    de Lamballerie, Xavier
    Solas, Caroline
    Nougairede, Antoine
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
    Ismail Celik
    Meryem Erol
    Zekeriya Duzgun
    Molecular Diversity, 2022, 26 : 279 - 292
  • [7] RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target
    Wang, Yanyan
    Anirudhan, Varada
    Du, Ruikun
    Cui, Qinghua
    Rong, Lijun
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 300 - 310
  • [8] Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex
    Deval, Jerome
    Gurard-Levin, Zachary A.
    MOLECULES, 2022, 27 (09):
  • [9] Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex
    Olotu, Fisayo A.
    Omolabi, Kehinde F.
    Soliman, Mahmoud E. S.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2021, 79 (02) : 175 - 187
  • [10] Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
    Pruijssers, Andrea J.
    George, Amelia S.
    Schafer, Alexandra
    Leist, Sarah R.
    Gralinksi, Lisa E.
    Dinnon, Kenneth H., III
    Yount, Boyd L.
    Agostini, Maria L.
    Stevens, Laura J.
    Chappell, James D.
    Lu, Xiaotao
    Hughes, Tia M.
    Gully, Kendra
    Martinez, David R.
    Brown, Ariane J.
    Graham, Rachel L.
    Perry, Jason K.
    Du Pont, Venice
    Pitts, Jared
    Ma, Bin
    Babusis, Darius
    Murakami, Eisuke
    Feng, Joy Y.
    Bilello, John P.
    Porter, Danielle P.
    Cihlar, Tomas
    Baric, Ralph S.
    Denison, Mark R.
    Sheahan, Timothy P.
    CELL REPORTS, 2020, 32 (03):
12345